| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.23 | 5e-10 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-09 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.27 | 3e-07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |